GALNOBAX
Phase I/II trials for DFU potential drug successful: NovaLeadPune-based NovaLead Pharma today announced completion of global phase I/II clinical trial of its repositioned investigational drug, Galnoba...- NovaLead to take PE route for expansionPune-based drug discovery startup NovaLead Pharma has begun talks with an overseas consortium of private equity funds as part of a plan to ...
- Load More